2027 Preliminary Agenda





Clinical Trial Venture, Innovation & Partnering
Accelerating Innovation, Accessibility, and Scale
3/1/2027 - March 2, 2027 ALL TIMES EST
As part of the renowned 18th Annual SCOPE Summit, the 5th Annual Clinical Trial Venture, Innovation & Partnering Conference, taking place March 1-2, 2027, offers a focused, executive-level platform designed for forward-thinking investors, corporate leaders, and entrepreneurs shaping the future of clinical research. This high-impact, boutique event convenes a distinguished audience of C-suite executives from investment firms, growth-stage and mature companies, large pharma, hospitals, and corporate venture arms. With a dual focus on current market dynamics and long-term forecasting, this conference delivers actionable insights into emerging investment trends, scalable innovation strategies, and the evolving landscape of clinical trial partnerships. Attendees will benefit from candid discussions, fireside chats, and curated panels led by industry pioneers, covering capital allocation strategies, innovation pipelines, regulatory tailwinds, and risk-adjusted returns. Explore the exhibit hall featuring high-growth start-ups and established players, and gain visibility into breakthrough technologies, investment-grade opportunities, and strategic collaborations that will define the clinical trial ecosystem over the next decade. Whether you're seeking to inform your investment thesis, identify acquisition targets, or shape your corporate venture strategy, this event is engineered to support long-term value creation, portfolio growth, and strategic decision-making.
Preliminary Agenda

Market Overview

Photo of Shane C. Senior, Managing Director & Owner, Crosstree Capital Partners, Inc. , Managing Director & Owner , Crosstree Capital Partners Inc
Shane C. Senior, Managing Director & Owner, Crosstree Capital Partners, Inc. , Managing Director & Owner , Crosstree Capital Partners Inc

Panel Moderator:

PANEL DISCUSSION:
Investor Outlook

Dave Stevenson, COO & Managing Director, Merck Global Health Innovation Fund , Managing Director , Global Health Innovation Fund , Merck

Panelists:

Jennifer Lum, Co-Founder & Managing Partner, Biospring , Co Founder & Managing Partner , Biospring

Megann Vaughn Watters, Vice President, New Ventures & Strategic Alliances, Labcorp , Vice President, New Ventures & Strategic Alliances , Labcorp

Panel Moderator:

PANEL DISCUSSION:
Building the Next Breakthroughs in Clinical Trial Innovation

Rana Lonnen, Life Sciences and Healthcare Investor , Life Sciences and Healthcare Investor

Panelists:

Scott Chetham, PhD, CEO & Co-Founder, Faro Health , CEO & Co-Founder , Exec , Faro Health

Ariel B. Katz, CEO & Co-Founder, H1 , CEO & Co Founder , H1

Zach Taft, CEO, IgniteData , CEO , IgniteData

Panel Moderator:

PANEL DISCUSSION:
Beyond the Pilot: What Big Pharma Leaders are Actually Scaling in Clinical Development

Jeremy Goldberg, Operating Partner, Healthcare, Arsenal Capital Partners , Operating Partner , Healthcare , Arsenal Capital Partners

Panelists:

John R. Pavletic, Executive Director, Lilly Ventures , Executive Director , Lilly Ventures

Panel Moderator:

PANEL DISCUSSION:
Autonomous Clinical Trials: How Close are We?

Sunny Kumar, MD, Partner, Informed Ventures , MD, Partner , Informed Ventures

Panelists:

Laura Y. Hilty, Principal, Investments & Growth, HealthX Ventures; Chief Strategy Officer, IgniteData , Principal , Investments & Growth , HealthX Ventures

Michelle Longmire, Co-Founder & CEO, Medable, Inc. , Co Founder & CEO , Medable Inc

Breakfast

BREAKFAST PRESENTATION

SCOPE Plenary Keynote - Monday

MONDAY GOLF, WORKSHOPS & USER GROUPS

SCOPE’s 6th Annual Masters of Clinical Research Golf Tournament* (Sponsorship Opportunities Still Available)

*Separate Registration Required

OPEN WORKSHOP: Modernizing Informed Consent: AI, Automation, and Ethics in Global Clinical Trials

MONDAY AFTERNOON PLENARY KEYNOTES

Grab Your Seat: Early-Bird Seat Golden Ticket Raffle & Prize Giveaway*

Photo of Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

*Must be present to win!

Organizer's Welcome Remarks & 6th Annual Masters of Clinical Research Golf Tournament Awards and Jacket Signing

Photo of Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research

Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine

Panelists:

Nikki Amaratunge, Vice President, Clinical Development Operations, Head of Clinical Site Management, AbbVie, Inc. , VP Clinical Dev Operations , Head of Clinical Site Management , AbbVie

Elizabeth Rogers, Vice President, Head, R&D Clinical Operations, Portfolio Development, CSL Behring , VP , Head, R&D Clinical Operations, Portfolio Development , CSL Behring

Melinda M. Rottas, Vice President, Head of Optimization, Analytics & Recruitment Solutions, Pfizer Inc. , VP, Head of Optimization , Analytics & Recruitment Solutions , Pfizer Inc

SCOPE Announcements: Tips for Getting the Most out of SCOPE

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: SCOPE's 4th Annual Site Innovation Awards

Irfan Khan, CEO, Circuit Clinical , CEO , Circuit Clinical

Amanda Wright, Co-Founder & Senior Vice President, Healthcare Alliance, Javara , Co-Founder & SVP , Healthcare Alliance , Javara

Panelists:

Karen Correa, PhD, Vice President, Development Operations, Boehringer Ingelheim , Vice President , Clinical Development Operations , Boehringer Ingelheim

Angela DeLuca, Vice President, Global Head, Site Management & Monitoring, AstraZeneca , VP & Global Head Site Management & Monitoring , Site Management & Monitoring , AstraZeneca

Joe Dustin, Senior Director, Digital Clinical Development, Sanofi , Senior Director, Digital Clinical Development , Digital Clinical Development , Sanofi

Sean Soth, Senior Vice President, Strategy and Global Business Partnerships, SCRS , Senior Vice President , Society for Clinical Research Sites (SCRS)

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Kelly McKee, Vice President, Strategy & Transformation, Science 37; Co-Creator of the SCOPE Participant Engagement Award , Vice President, Strategy & Transformation , Science37

David Sall, President & CEO, Marketing, Patient Enrollment Advisors LLC; Co-Creator of the SCOPE Participant Engagement Award , President & CEO , Marketing , Patient Enrollment Advisors LLC

Panelists:

Andrea Bartucca, Director, Trial Awareness and Recruitment, Rapport Therapeutics , Director, Trial Awareness , Trial Awareness and Recruitment , Rapport Therapeutics

Sarah Bednarski, MS, Senior Director, Head Clinical Operations (ad interim), BlueRock Therapeutics , Sr. Director, Head Clinical Operations (ad interim) , Clinical Operations , BlueRock Therapeutics

Savine DaCosta, PhD, Clinical Trial Access and Representation Site Lead, Biogen , Clinical Trial Access and Representation Site Lead , Biogen

Anita Difrancesco, Senior Vice President, Clinical Operations, Endeavor Biomedicines , SVP , Clinical Operations , Endeavor Biomedicines

Gretchen Goller, Head, Recruitment and Retention, Pfizer Inc. , Head , Recruitment and Retention , Pfizer Inc.

April Lewis, Clinical Solutions, PatientPartner; Strategic Advisor, ZS , Sr. Director, Innovative Health , Global Development , Johnson & Johnson Innovative Medicine

Wendy Lurrie, Acting Head of Comms, BestGuessistan , Acting Head of Comms

Adrienne Walstrum, Senior Director, Global Trial Optimization, Merck , Senior Director , Global Trial Optimization , Merck & Co

Kate Wilson, Senior Director, Head of Global Clinical Trial Access & Representation, Biogen , Senior Director , Head of Global Clinical Trial Access & Representation , Biogen

SCOPE's Kickoff Reception—Welcome to the Wild Wild West! (Sponsorship Opportunities Available)

SCOPE Plenary Keynote - Tuesday

TUESDAY MORNING EXERCISE & COFFEE

SCOPE's Morning Fun Run! (Sponsorship Opportunities Available)

COORDINATOR: 

Bridget Kotelly, Senior Director, Cambridge Healthtech Institute

Get up & Go Specialty Coffee (Sponsorship Opportunities Available)

TUESDAY PLENARY KEYNOTES

SCOPE’s Stretch Break & Annual T-Shirt Toss (Sponsorship Opportunity Available)

Photo of Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Grab Your Seat: Early-Bird Seat Raffle & Prize Giveaway!* (Sponsorship Opportunity Available)

Photo of Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute
Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

*Must be present to win!

Welcome to SCOPE Europe 2027—Saddle up for the Future of Clinical Trials

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

KEYNOTE FIRESIDE CHAT: The Other Side of Drug Development: Pharma Leader's Journey as a Rare Disease Parent

Photo of Craig Lipset, Founder, Advisor, Clinical Innovation Partners; Co-Chair, Decentralized Trials & Research Alliance (DTRA) , Co Chair , Decentralized Trials & Research Alliance DTRA
Craig Lipset, Founder, Advisor, Clinical Innovation Partners; Co-Chair, Decentralized Trials & Research Alliance (DTRA) , Co Chair , Decentralized Trials & Research Alliance DTRA
Photo of Casey McPherson, CEO and Founder, AlphaRose Therapeutics , CEO and Founder , AlphaRose Therapeutics
Casey McPherson, CEO and Founder, AlphaRose Therapeutics , CEO and Founder , AlphaRose Therapeutics
Photo of Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen
Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen

For leaders who have spent their careers developing medicines, the experience of navigating a rare disease within their own family can bring an entirely different perspective to the urgency, complexity, and human impact of drug development. This fireside conversation will explore that intersection: what changes when an industry leader experiences drug development and clinical research as a parent, what the industry can learn from that perspective, and how it can inform the way we develop medicines and design clinical trials for patients and families.

KEYNOTE FIRESIDE CHAT: From Reform to Implementation: FDA’s New Clinical Trial Innovation Office and Operation Trialblazer

Photo of Kevin Bugin, PhD, Associate Vice President, Head, Global Regulatory Policy and Intelligence, Amgen , Head , Regulatory Policy and Intelligence , Amgen
Kevin Bugin, PhD, Associate Vice President, Head, Global Regulatory Policy and Intelligence, Amgen , Head , Regulatory Policy and Intelligence , Amgen
Photo of Dianne Paraoan, Director, Office of Medical Policy, Office of New Drugs, CDER, FDA , Director , Office of Medical Policy, Office of New Drugs, CDER , FDA
Dianne Paraoan, Director, Office of Medical Policy, Office of New Drugs, CDER, FDA , Director , Office of Medical Policy, Office of New Drugs, CDER , FDA

FDA’s clinical-trial modernization agenda is moving from policy ambition to implementation. This plenary discussion will explore the new clinical-trial-innovation office being established within CDER’s Office of Medical Policy, Operation Trialblazer, and related FDA priorities. The conversation will focus on the office’s intended role, near-term priorities, opportunities to leverage existing industry capabilities, and what sponsors, sites, and research partners should anticipate as the work takes shape.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible?

Micky Cohen-Wolkowiez, MD, PhD, Executive Director, i-Cubed, Duke Clinical Research Institute , i-Cubed Executive Director , Duke Clinical Research Institute

Panelists:

Zhanna Jumadilova, MD, Biopharmaceutical Physician Executive, Pragmatic Clinical Trials, R&D, Pfizer Inc. , Pragmatic Trials Clinical Lead , Pragmatic Clinical Trials, R&D , Pfizer

Christoph Koenen, MD, Head of Clinical Development & Operations, Pharma R&D, Bayer , Head of Clinical Development & Operations , Pharma Research & Development , Bayer

Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen

Grand Opening Coffee & Refreshment Break in the Exhibit Hall (Sponsorship Opportunities Available)—Best of Show Voting Opens

SCOPE Plenary Keynote - Wednesday

WEDNESDAY PLENARY KEYNOTES

Organizer's Welcome Remarks

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient

Darren Weston, Head, Integrated Data Analytics and Reporting, Johnson & Johnson , Head , Integrated Data Analytics and Reporting , Johnson & Johnson

Panelists:

Michael Cantor, Vice President, Data Technology & Innovation, Regeneron Pharmaceuticals, Inc. , Vice President , Data Technology & Innovation , Regeneron Pharmaceuticals Inc

Justine Rochon, Senior Vice President, Head of R&D Data and Quantitative Sciences, Takeda , SVP , Head of R&D Data and Quantitative Sciences , Takeda

Sammi Rui Tang, PhD, Senior Vice President & Global Head, Quantitative Sciences & Evidence Generation, Astellas Pharma, Inc. , Sr VP & Global Head , Quantitative Sciences & Evidence Generation , Astellas Pharma Inc

Rachel Nering, Vice President, Head of Early Development and eDevelopment, Sanofi , VP , Head of Early Development and eDevelopment , Sanofi

SCOPE’s Booth Crawl (Sponsorship Opportunities Available) & Last Chance for Exhibit Viewing

SCOPE Plenary Keynote - Thursday

THURSDAY PLENARY KEYNOTES

Organizer's Welcome Remarks

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

KEYNOTE PRESENTATION: Case Study: AI and the R&D Revolution: Reinventing Drug Development from Discovery to Clinical Trials

Photo of Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences , SVP Clinical Data Science , Clinical Data Science , Gilead Sciences
Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences , SVP Clinical Data Science , Clinical Data Science , Gilead Sciences
Photo of Dan Sheeran, Vice President & General Manager, Healthcare & Life Sciences, AWS , VP & GM Healthcare & Life , Healthcare & Life Sciences , AWS
Dan Sheeran, Vice President & General Manager, Healthcare & Life Sciences, AWS , VP & GM Healthcare & Life , Healthcare & Life Sciences , AWS

AI is reshaping R&D from discovery through clinical development. This case study will explore how organizations are applying AI at scale to accelerate innovation, improve decision-making, and transform how new medicines are developed.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: The New Clinical Development Operating Model

Kristi Koontz, Vice President, Global Study and Site Operations, Amgen , VP , Global Study and Site Operations , Amgen

Panelists:

David Carruthers, Vice President, BioPharmaceuticals R&D Clinical Operations, AstraZeneca , Vice President , BioPharmaceuticals R&D Clinical Operations , AstraZeneca

Nick Hodges, Senior Vice President & Head, Clinical Development Operations & R&D Transformation Office, Ipsen , SVP, Head of Global Clinical Development , Global Clinical Operations , Ipsen

Henry Wei, MD, Executive Director, Development Innovation, Regeneron , Executive Director , Development Innovation , Regeneron Pharmaceuticals Inc

Wrap up SCOPE with Closing Remarks and Lunch, Courtesy of Our Sponsors!

SCOPE Summit 2027 Adjourns

If you have a compelling story to share with innovators, investors, and executives attending this boutique event, we encourage you to submit a speaking proposal.

Please note that the vast majority of speakers are identified, selected, and invited by our summit chairs and advisory board members. As we receive a high volume of submissions, we regret that Cambridge VIP can only be in contact with those deemed optimal candidates.

To become a sponsor, click here.

CONFERENCE CONTENT
Julia Boguslavsky
Executive Director, Conferences
Email: juliab@healthtech.com

PARTNERING & SPONSORSHIP
Craig Simak
Executive Director, Conferences
Phone: (+1) 516-835-9109
Email: csimak@healthtech.com